Must Read Rumors

Prince Harry calls Duchess Kate the ‘big sister he never had’

The royal recently made a sweet revelation about his sister-in-law.

Duchess Kate’s next engagement scheduled at Victoria and Albert Museum

Prince William’s wife is set to visit the Victoria and Albert Museum in London next week.

Duchess Kate isn’t pregnant with baby no.3, despite report

A new rumor has surfaced, claiming that the royal couple is expecting their third child.

Meghan Markle avoids Prince Harry questions at ATX panel

Meghan Markle was faced with the question that everyone is curious about.

Kate Middleton and Prince William to embark on royal tour of Poland and Germany

The Duke and Duchess of Cambridge, née Kate Middleton, have announced an official visit to the two countries in July.

Prince Harry calls Duchess Kate the ‘big sister he never had’
Duchess Kate’s next engagement scheduled at Victoria and Albert Museum
Duchess Kate isn’t pregnant with baby no.3, despite report
Meghan Markle avoids Prince Harry questions at ATX panel
Kate Middleton and Prince William to embark on royal tour of Poland and Germany

A new plan for a drug against HIV

by Julia
August 22, 2011 at 1:12 am

A new drug that causes HIV to mutate could eventually entirely eliminate the virus in people suffering from it.

The discovery of a drug to cure HIV is a large-scale business. Currently, the market for HIV drugs has reached $ 14 billion, which means $ 600,000 to treat a single patient.

These drugs are designed to suppress and prevent virus propagation, but have many disadvantages, including cost, side effects and that patients depend on them for life.

Koronis Pharmaceuticals, a biotechnology company, has found a possible solution with KP-1461, a new drug that causes mutations in cells affected by HIV. If it will work, patients could get off the drug and recover from AIDS.

KP-1461 uses a new mechanism, called Viral Decay Acceleration T, to insert itself into the viral genome and accelerate the frequency of mutations until the virus collapses.

“If you think of HIV as a house made of two by fours, and the genetic backbone of the virus as the foundation of that house, [the drug mechanism] replaces the two by fours with toothpicks, and eventually the house comes crashing down,” said Dr. Mark G. Fromhold, VP of Manufacturing and Business Development at Koronis.

Until now, the company has successfully tested the drug in the laboratory. testing patients will be much harder but it could be a breakthrough dicovery.

The downside is that patients will have to take the medication for a long time. In the second stage of tests, Koronis will use a combination of therapies and will measure the exact time that the healing of the patients takes. The company wants to raise $ 15 million from business partners for further study.

Filled under: ,

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions